top of page

Montie Makietie 2025

Public·3 members

aashish kumar
aashish kumar

Technological Innovations and Market Drivers in the US Ureteral Stents Market: Enhancing Patient Outcomes through Material Science and Design

The US Ureteral Stents Market is poised for substantial growth, with estimations showing an increase from about USD 130 million in 2024 to nearly USD 240 million by 2035, reflecting a CAGR of approximately 5.732%. A major force fueling this market is innovation in stent design and materials—manufacturers are focusing on biocompatible polymers, drug-eluting coatings, biodegradable materials, and designs that reduce encrustation and minimize irritation. Meanwhile, demand is rising due to increasing prevalence of urological disorders—kidney stones, urinary tract infections, and blockage due to strictures—and the growing elderly population in the US. Advances in minimally invasive surgery also encourage stent use, as urologists and device makers work together to reduce patient discomfort, risk of complications, and recovery times. Regulatory oversight by the FDA ensures that new stent solutions meet safety and efficacy standards, which pushes continual improvement in product design.


Behind the numbers, clinical outcomes and patient experience are becoming central in product development. Double pigtail stents are among the most common design types used, due to their reliable anchoring and patient comfort. Polymers remain popular for their flexibility and lower cost, while metallic stents are also used for higher durability in chronic cases. Hospitals are the primary setting for stent deployment, though ambulatory surgical centers are increasing their role with outpatient procedures. Challenges include managing encrustation, infections, and ensuring that patient awareness and education lead to early diagnosis and treatment. In addition, cost pressures from payers and insurers, and the need for devices that combine functional performance with ease of placement and removal, shape R&D priorities. Overall, the US Ureteral Stents Market is moving toward more patient-centred, technologically advanced, and cost-efficient solutions.

 

Members

  • aashish kumar
    aashish kumar
  • Pieter
    Pieter
  • beliciabelicia
    belicia
bottom of page